Type-2 diabetes: Current understanding and future perspectives

IUBMB Life

Volumn 67, Issue 7, 2015, Pages 506-513

  Pandey, Ankita ^a   Chawla, Sheetal ^a   Guchhait, Prasenjit ^a  

^a REGIONAL CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

dyslipidemia; insulin resistance; intrauterine programming; obesity; thrifty phenotype and inflammation; type 2 diabetes

Indexed keywords

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETIC PATIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; FUTUROLOGY; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PREVALENCE; RISK FACTOR; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIET; DYSLIPIDEMIAS; FEMALE; INDIA; OBESITY; PATHOPHYSIOLOGY; PREGNANCY;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIET; DYSLIPIDEMIAS; FEMALE; HUMANS; INDIA; INSULIN RESISTANCE; OBESITY; PREGNANCY; RISK FACTORS;

EID: 84937976664     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1396     Document Type: Article

References (60)

1. Laslett, L. J., Alagona, P. Jr., Clark, B. A. 3rd, Drozda, J. P. Jr., Saldivar, F., et al., (2012) The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J. Am. Coll. Cardiol. 60, S1-S49.
2. Mendis, S., Davis, S., and, Norrving, B., (2015) Organizational update: The World Health Organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke 46, e121-e122.
3. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., et al., (2014) Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129, e28-e292.
4. Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., et al., (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134-1146.
5. Wild, S., Roglic, G., Green, A., Sicree, R., and, King, H., (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 27, 1047-1053.
6. Reddy, K. S., (2009) Regional case studies-India. Nestle Nutr. Workshop Ser. Pediatr. Program 63, 15-24. Discussion, 41-16, 259-268.
7. Anjana, R. M., Pradeepa, R., Deepa, M., Datta, M., Sudha, V., et al., (2014) Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 54, 3022-3027.
8. Ramachandran, A., Ma, R. C., and, Snehalatha, C., (2010) Diabetes in Asia. Lancet 375, 408-418.
9. Ershow, A. G., (2009) Environmental influences on development of type 2 diabetes and obesity: challenges in personalizing prevention and management. J. Diab. Sci. Technol. 3, 727-734.
10. Paneni, F., Beckman, J. A., Creager, M. A., and, Cosentino, F., (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur. Heart J. 34, 2436-2443.
11. Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., et al., (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diab. Res. Clin. Pract. 103, 137-149.
12. Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., et al., (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49, 289-297.
13. Ramachandran, A., Snehalatha, C., Baskar, A. D., Mary, S., Kumar, C. K., et al., (2004) Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia 47, 860-865.
14. Popkin, B. M., (2001) Nutrition in transition: the changing global nutrition challenge. Asia Pac.J Clin. Nutr. 10, S13-S18.
15. Hu, F. B., Li, T. Y., Colditz, G. A., Willett, W. C., and, Manson, J. E., (2003) Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. J. Am. Med. Assoc. 289, 1785-1791.
16. Bell, A. C., Ge, K., and, Popkin, B. M., (2002) The road to obesity or the path to prevention: motorized transportation and obesity in China. Obes. Res. 10, 277-283.
17. Mohan, V., Jaydip, R., and, Deepa, R., (2007) Type 2 diabetes in Asian Indian youth. Pediatr. Diabetes 8, 28-34.
18. Kim, C., Newton, K. M., and, Knopp, R. H., (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diab. Care 25, 1862-1868.
19. Ross, M. G., and, Desai, M., (2005) Gestational programming: population survival effects of drought and famine during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R25-R33.
20. Tam, W. H., Ma, R. C., Yang, X., Ko, G. T., Tong, P. C., et al., (2008) Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics 122, 1229-1234.
21. Veeraswamy, S., Vijayam, B., Gupta, V. K., and, Kapur, A., (2012) Gestational diabetes: the public health relevance and approach. Diab. Res. Clin. Pract. 97, 350-358.
22. Godfrey, K. M., and, Barker, D. J., (2000) Fetal nutrition and adult disease. Am. J. Clin. Nutr. 71, 1344S-1352S.
23. Cox, A. R., Beamish, C. A., Carter, D. E., Arany, E. J., and, Hill, D. J., (2013) Cellular mechanisms underlying failed beta cell regeneration in offspring of protein-restricted pregnant mice. Exp. Biol. Med. 238, 1147-1159.
24. Yajnik, C. S., Fall, C. H., Coyaji, K. J., Hirve, S. S., Rao, S., et al., (2003) Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int. J. Obes. Relat. Metab. Disord. 27, 173-180.
25. Fall, C. H., Stein, C. E., Kumaran, K., Cox, V., Osmond, C., et al., (1998) Size at birth, maternal weight, and type 2 diabetes in South India. Diab. Med. 15, 220-227.
26. Antonisamy, B., Raghupathy, P., Christopher, S., Richard, J., Rao, P. S., et al., (2009) Cohort Profile: the 1969-73 Vellore birth cohort study in South India. Int. J. Epidemiol. 38, 663-669.
27. Leary, S., Fall, C., Osmond, C., Lovel, H., Campbell, D., et al., (2006) Geographical variation in neonatal phenotype. Acta Obstet. Gynecol. Scand. 85, 1080-1089.
28. Raji, A., Seely, E. W., Arky, R. A., and, Simonson, D. C., (2001) Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J. Clin. Endocrinol. Metab. 86, 5366-5371.
29. Habbout, A., Li, N., Rochette, L., and, Vergely, C., (2013) Postnatal overfeeding in rodents by litter size reduction induces major short- and long-term pathophysiological consequences. J. Nutr. 143, 553-562.
30. Deurenberg, P., Deurenberg-Yap, M., and, Guricci, S., (2002) Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes. Rev. 3, 141-146.
31. Yajnik, C. S., (2004) Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J. Nutr. 134, 205-210.
32. Lubree, H. G., Rege, S. S., Bhat, D. S., Raut, K. N., Panchnadikar, A., et al., (2002) Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr. Bull. 23, 146-149.
33. Bhattacharya, S., Dey, D., and, Roy, S. S., (2007) Molecular mechanism of insulin resistance. J. Biosci. 32, 405-413.
34. Zick, Y., (2001) Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell. Biol. 11, 437-441.
35. Paz, K., Hemi, R., LeRoith, D., Karasik, A., Elhanany, E., et al., (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272, 29911-29918.
36. Group, U. P. D. S. U., (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853.
37. Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., et al., (2008) Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371, 1753-1760.
38. Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C. Jr., Bigger, J. T., et al., (2008) Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545-2559.
39. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., et al., (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174.
40. UKPDS. (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 854-865.
41. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. W., et al., (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677.
42. Goldfine, A. B., Fonseca, V., Jablonski, K. A., Chen, Y. D., Tipton, L., et al., (2013) Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 159, 1-12.
43. Quan, W., Jo, E. K., and, Lee, M. S., (2013) Role of pancreatic beta-cell death and inflammation in diabetes. Diab. Obes. Metab. 15, 141-151.
44. Clark, A., Saad, M. F., Nezzer, T., Uren, C., Knowler, W. C., Bennett, P. H., and, Turner, R. C., (1990) Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 33, 285-289.
45. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., et al., (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403.
46. Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., and, Dubbert, P. M., (2002) Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324, 127-137.
47. Gopalan, C., (2001) Rising incidence of obesity, coronary heart disease and diabetes in the Indian urban middle class. Possible role of genetic and environmental factors. World Rev. Nutr. Diet 90, 127-143.
48. Mohan, V., Shanthirani, S., Deepa, R., Premalatha, G., Sastry, N. G., et al., (2001) Intra-urban differences in the prevalence of the metabolic syndrome in southern India-The Chennai Urban Population Study (CUPS No. 4). Diabet. Med. 18, 280-287.
49. Wellen, K. E., and, Hotamisligil, G. S., (2005) Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119.
50. Shoelson, S. E., Lee, J., and, Goldfine, A. B., (2006) Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801.
51. Randle, P. J., Garland, P. B., Hales, C. N., and, Newsholme, E. A., (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
52. Boden, G., (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46, 3-10.
53. Shulman, G. I., (2000) Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171-176.
54. McGarry, J. D., (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7-18.
55. Arca, M., Montali, A., Valiante, S., Campagna, F., Pigna, G., et al., (2007) Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am. J. Cardiol. 100, 1511-1516.
56. Mooradian, A. D., (2009) Dyslipidemia in type 2 diabetes mellitus. Nat. Clin. Pract. Endocrinol. Metab. 5, 150-159.
57. Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., et al., (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27, 84-91.
58. Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., et al., (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18, 1279-1285.
59. DeMaria, E. J., (2007) Bariatric surgery for morbid obesity. N. Engl. J. Med. 356, 2176-2183.
60. Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., et al., (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am. J. Med. 122, 248-256. e245.